GSK
WAITGSK plc
$50.01
-0.08%delayed
News – · Trend – · inside triggers –
Expected move (1d)
▼ $48.89to$51.13 ▲
ATR ±$1.12 (+2.24%)Implied ±$1.08 (+2.15%)
Entry Reference
Price / prev close$50.01 / $50.05
Day range$49.63 – $50.16
52-wk range$39.29 – $61.70(48%)
Volume vs avg0.75×
ATR (14d)$1.12
MA 8 / 21$49.33 / $50.48
MA 50 / 200$51.27 / $52.33
Call ▲ / Put ▼ trigger$50.31 / $49.79
+1 / +2 ATR$51.13 / $52.25
-1 / -2 ATR$48.89 / $47.77
Support: 49.89 49.39 48.86
Resistance: 50.43 51.52 52.11
Near-the-money contracts
exp 2026-09-18Calls
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 48.5 | $1.68 | 51% | 0.77 | -0.13 | 38 |
| 49 | $1.23 | 48% | 0.70 | -0.14 | 11 |
| 49.5 | $0.85 | 40% | 0.63 | -0.13 | 234 |
| 50 | $0.55 | 36% | 0.51 | -0.12 | 790 |
| 51 | $0.20 | 38% | 0.28 | -0.10 | 247 |
| 52 | $0.09 | 42% | 0.14 | -0.08 | 257 |
Puts
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 48.5 | $0.13 | 40% | -0.18 | -0.08 | 96 |
| 49 | $0.20 | 39% | -0.26 | -0.10 | 148 |
| 49.5 | $0.28 | 32% | -0.34 | -0.09 | 65 |
| 50 | $0.53 | 36% | -0.49 | -0.11 | 1617 |
| 51 | $1.13 | 38% | -0.72 | -0.10 | 43 |
| 52 | $2.03 | 47% | -0.83 | -0.09 | 19 |
Δ = delta (≈ probability ITM), θ/day = daily time decay, IV = implied vol. Greeks computed via Black-Scholes from Yahoo IV.
Recent news
- GSK plc (GSK) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript10h ago
- GSK to Acquire Experimental Blood Cancer Therapy From Chimagen in $750 Million Deal15h ago
- GSK splashes up to $750m on experimental cancer therapy19h ago
- Finding Value Opportunities Among Highly Rated Stocks1d ago
- INCY Stock Gains 23% Year to Date: Buy, Sell or Hold?1d ago
- GSK Presents Jideytro Data for Potential Use in First-Line NSCLC1d ago
- GSK Gets a Lung Cancer Payoff1d ago
- Why Is GSK Stock Gaining Monday?2d ago
- Big Pharma Is Pouring Billions Into China’s Biotechs2d ago
- GSK's Jideytro Achieves 94% Objective Response Rate At 15.2 Months Follow-Up In TKI-Naïve ROS1-Positive NSCLC, ARROS-1 Trial Shows2d ago
- GSK Targets £1.9B Savings to Fuel Pipeline, Navigate HIV Patent Cliff3d ago
- GSK Says Plans To Stop Manufacturing At Co's Dresden, Germany Flu Vaccine Manufacturing Site In Summer 20275d ago
Reference data only. Not a recommendation. Greeks and expected-move figures are estimates, not certainties. You confirm all entries and contracts in TradingView and Charles Schwab.